• Wed. May 22nd, 2024

Tackling Technology Transfer Challenges in Cell and Gene Therapy: Roberto Formisano Discusses Complexities and Implications

BySamantha Jones

Mar 27, 2024
Advancements in technology transfer to a Contract Development and Manufacturing Organization

In a video interview, Roberto Formisano, Process Transfer Senior Manager at AGC Biologics, discusses the challenges associated with technology transfer in the cell and gene therapy industry. He highlights the complexities involved in transferring technology from development to GMP manufacturing as well as from a customer to a contract development and manufacturing organization (CDMO).

Roberto emphasizes the critical timelines that present the biggest challenges in technology transfer. He explains how balancing the number of batches that need to be manufactured is essential to ensuring sufficient and scientifically quality data within these timelines.

During his conversation with EPR editor Caroline Peachey at Terrapin’s Advanced Therapies conference in London on 19 March, Roberto delves into the nuances of technology transfer and its implications for the industry. He also shares his insights on the technology and manufacturing trends and priorities that he foresees for the cell and gene therapy industry in 2024.

By Samantha Jones

As a content writer at newsnnk.com, I weave words into captivating stories that inform and engage our readers. With a passion for storytelling and an eye for detail, I strive to deliver high-quality and engaging content that resonates with our audience. From breaking news to thought-provoking features, I am dedicated to providing informative and compelling articles that keep our readers informed and entertained. Join me on this journey as we explore the world through the power of words.

Leave a Reply